PANZYGA®

Panzyga®

FDA INDICATION: Primary immunodeficiency (PI), idiopathic thrombocytopenic purpura (ITP) Package Insert

FORM: Liquid

DISTRIBUTOR: Octapharma

ROUTE OF ADMINISTRATION: Intravenous

PH (AFTER RECONSTITUTION): 4.5–5

CONCENTRATION: 10%

IGA CONTENT: 100 μg/mL (average)

% IGG: ≥96%

NA CONTENT: Trace amounts

DILUENT: N/A

OSMOLALITY: 240–310 mOsm/kg

INITIAL INFUSION RATE: 0.01 mL/kg/min

MAXIMUM INFUSION RATE (IF TOLERATED):  PI: 0.12 or 0.14 mL/kg/min  ITP: 0.08 mL/kg/min

SUGAR CONTENT: No added sugars

SHELF LIFE: 24 months (refrigerated). Within its shelf life, the product may be stored at ≤25°C (77°F) for up to 9 months. 

STORAGE REQUIREMENTS: Refrigeration: 2–8°C (36–46°F)

FLUSHING COMPATIBILITY: Saline or dextrose 

OTHER WEBSITES: panzyga.info